The global flavored yogurt market size is expected to reach USD 59.2 billion by 2027, expanding at a CAGR of 6.9% in the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the changing dietary habits and increasing health awareness among consumers. The consumption of the flavored yogurt has been on the rise in the recent past years owing to the factor such as increasing disposable income of middle-age group. Growing popularity of flavored yogurt as dessert option which acts as a ready to eat food item and a rising demand from developing countries are considered to be major factors fueling the growth in the market. The flavored yogurts can be classified into drinkable and spoonful ranges wherein fruit flavored yogurts such as strawberry, blueberry, raspberry are possessing high competition to the ice-creams or desserts. Health issues such as high calorie, fat can be resolved by the low-fat flavored yogurts as a good alternative option for ice-creams and desserts.
Key suggestions from the report:
- In terms of revenue, the strawberry segment is projected to ascend at a CAGR of 7.6% over the forecast years
- The convenience stores segment accounts for more than 30.0% flavored yogurt market share in 2019
- Europe is one of the fastest growing regions and it is growing at a significant 7.0% CAGR due to growing popularity of flavoured yogurt, Greek yogurt as a diet food item, and increasing disposable income especially in France and Germany.
Read 80 page research report with ToC on “Flavored Yogurt Market Size, Share & Trends Analysis Report By Flavor (Strawberry, Blueberry, Vanilla, Peach), By Distribution Channel (Supermarket, Convenience Stores, Online), By Region, And Segment Forecasts, 2020 – 2027” at: https://www.grandviewresearch.com/industry-analysis/flavored-yogurt-market
Strawberry accounts for the majority of share in the segmentation based on flavor. It accounted for more than 33.0% of the market share in 2019 and is witnessing a significant growth over the period of time. Increasing consumer’s affinity for fruit flavored yogurt is led by the berry fruits such as strawberry, blueberry, and raspberry. These fruits flavored yogurt possesses health-related attributes like light and fat-free elements, which is expected to drive the overall market.
Supermarkets is found to be the market dominator in the segment based on distribution channel and accounts for more than 45.0% of the market share in 2019. With larger access to customer base, major players focus on retailing their food items through supermarkets. The convenience stores segment is also expected to have significant market growth in the forecast period. The segment is mainly driven by the convenient shops and grocery shops where dairy products are easily available in variety of flavors. The online segment is also expected to grow moderately during the forecast period. According to American Pantry Study in 2015, 37.0% consumers use their mobile for shopping. This, in turn, will influence the growth of the overall flavored yogurt market.
Europe held the leading market share of more than 30.0% in 2019. The rapid changes in dietary habits along with increase in disposable income is among the prominent factor for the region to dominate. Asia pacific is found to be the fastest growing region and is witnessing a significant CAGR of more than 7.8% CAGR in the forecast period. The growing popularity of the flavored yogurt and shift in consumer behaviors style with dietary habits and willingness to spend more for high quality product is impacting the market to grow faster in the forecast period.
Grand View Research has segmented the global flavored yogurt market on the basis of flavor, distribution channel, and region:
- Flavored Yogurt Outlook (Revenue, USD Million, 2016 – 2027)
- Flavored Yogurt Distribution Channel Outlook (Revenue, USD Million, 2016 – 2027)
- Convenience Stores
- Flavored Yogurt Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- Asia Pacific
- Central & South America
- Middle East & Africa
- South Africa
- North America
Find more research reports on Consumer F&B Industry, by Grand View Research:
- Pet Supplements Market – Key factors driving the market include changes in socio-economic aspects and inclination towards the humanization of animals.
- Cannabis Beverages Market – The global cannabis beverages market size was valued at USD 901.8 million in 2018 and is expected to expand at a CAGR of 17.8% from 2019 to 2025. Rising demand for wellness drinks is anticipated to drive the growth.
- Powdered Sugar Market – Increasing consumption of confectionery and bakery food products is the key factor propelling the market growth.
SOURCE Grand View Research, Inc.
MediPharm Labs and Ace Valley Deliver Innovative Vapes – Now Available in Several Markets Across Canada
TORONTO, May 25, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its highly anticipated and innovative suite of “Ace Valley Vapes” are officially available in several markets across Canada. The Company shipped three new vape products under this white label brand-line to multiple provinces last week.
The launch of the Ace Valley Vapes is the culmination of the Company’s previously announced white label agreement through its subsidiary, MediPharm Labs Inc., with AV Cannabis Inc. (d/b/a Ace Valley). Through this collaboration, Ace Valley leveraged its leading brand traction and product strategy expertise to design, brand and market new and innovative vaporizer products, while MediPharm Labs provided raw material from its supply chain, high-quality cannabis distillate, formulation and filling expertise from its GMP-certified facility, as well as distribution services across Canada to cannabis distributors and retailers.“Ace Valley has emerged as one of Canada’s true cannabis brands. We are proud to be partnering with a team that consistently raises the bar through product development and marketing ingenuity, further elevated by our superiour product formulations and top CPG-quality processes,” said Pat McCutcheon, Chief Executive Officer of MediPharm Labs.“We are passionately building a great cannabis brand in Canada,” said Mike Wagman, Chief Executive Officer of Ace Valley. “Our new all-in-one vapes, with an innovative logo light-up feature, are a big part of our platform and we have a strong partner in MediPharm Labs, the leader in cannabis extraction and purified cannabis concentrates in Canada.”Unique Product Formulations with Original Vape Hardware
Each Ace Valley Vape is an all-in-one unit with 0.3 ml of formulated cannabis distillate. Working in collaboration with Ace Valley, MediPharm Labs’ Applied Science team formulated three unique products – CBD, Sativa and Indica options – each comprised of 95% distillate and 5% botanically derived terpenes, with zero carrier oil, other additives, or thickening agents. Ace Valley selected this variety of vape options so consumers can curate their experience.The vape hardware is an all-in-one unit, not requiring a separate purchase of battery and vapourizer cartridge. Ace Valley wanted to offer customers something convenient, consistent, and easy-to-use. By providing an integrated all-in-one hardware device, they were able to deliver maximum consistency from one experience to the next, as the distillate and vapourizing hardware have been specifically designed and tested together.“The concept for our new vapes is the brainchild of our co-founder, Noah Gill, who wanted customers to have a fun way to experience the device,” explained Mike Wagman, CEO of Ace Valley. “Unlike other vape pens on the market, the Ace Valley Vape lights up each of the four colour bands in our logo sequentially as you inhale. This provides the customer with simple and intuitive control and a unique interaction.”Multi-Province Distribution
MediPharm Labs has already completed shipments to Ontario, BC and Alberta distribution hubs.
The Ace Valley Vapes are anticipated to be available at select retailers in ON, BC, Alberta, Manitoba, and Saskatchewan.About Ace Valley
Ace Valley is a leading recreational cannabis brand. Since launching in October 2018, Ace Valley has built a curated, ready-to-use portfolio of pre-rolls, vapes and real-fruit gummies* (*launching soon) with wholesale and retail distribution across most of Canada. Ace Valley drives leading sales and brand awareness by leveraging its product strategy expertise, consumer insights and loyal community of fans.About MediPharm Labs Corp.
Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, they formulate, consumer-test, process, package and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and is nearing commercialization of its Australian Extraction facility. MediPharm Labs Australia was established in 2017.For further information, please contact:
Laura Lepore, VP, Investor Relations
Telephone: +1 416.913.7425 ext. 1525
Website: www.medipharmlabs.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, expected sale of the Ace Valley Vapes at various provincial retailers. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs’ filings, available on the SEDAR website at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.All information contained in this press release with respect to Ave Valley was supplied by Ace Valley for inclusion herein.Photos accompanying this announcement are available athttps://www.globenewswire.com/NewsRoom/AttachmentNg/e0e9a2f1-456e-4d74-9b83-ed4292c56ea0https://www.globenewswire.com/NewsRoom/AttachmentNg/2795c368-8023-462a-a7ee-94d0418c39d1
GreenStar Biosciences Announces Stock Option Issuance and Cancellation of Stock Options
Vancouver, British Columbia–(Newsfile Corp. – May 25, 2020) – GreenStar Biosciences Corp. (CSE: GSTR) (“GreenStar” or the “Company”), announces it has granted stock options to acquire a total of 200,000 common shares of the Company to a director of the Company. The options are exercisable at a price of $0.14 per share and expire three years from the date of grant. The options are subject to various vesting provisions where 150,000 of the options granted vest immediately on the grant date, 7,143 options vest monthly from June 30, 2020 to November 30, 2020 and 7,142 options vest on December 31, 2020.
The Company also announces the cancellation of a total of 150,000 previously granted stock options made to a former director.
GreenStar is a growth-oriented technology and services company that provides real estate, financial, management, IP and branding support to licensed cannabis businesses in the United States. GreenStar operates a growing portfolio of tenant partner companies in the United States. GreenStar applies refined strategies tested in the Washington State market to help partner companies reach their full potential. Based in Vancouver, BC, GreenStar intends to facilitate growth through acquisitions and development of additional assets, products and technologies in legal cannabis markets by leveraging its capital markets, branding and operational expertise.
For further information please contact:
GreenStar Biosciences Corp.
Tom Baird, CEO
Telephone: (604) 834-9499
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56479
Matica Announces Delayed Filing of Interim Financial Statements Pursuant to OSC Blanket Instrument 51-502
Toronto, Ontario–(Newsfile Corp. – May 22, 2020) – Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) today announced that it will be delaying the filing and delivery of certain of its continuous disclosure documents, in accordance with Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements of the Ontario Securities Commission (the “Blanket Exemption Order”) which was adopted for the purpose of providing certain filing and other relief to issuers in light of the challenges posted by the COVID-19 pandemic.
The Company is relying on the Blanket Exemption Order in delaying the Company’s interim financial statements for the three month period ended March 31, 2020 and related certifications; and the Company’s management discussion and analysis for the three month period ended March 31, 2020.
The officers and directors of the Company and certain other persons will remain subject to a trading black-out pursuant to which such persons are prohibited from trading in any securities of the Company until the end of the second full trading day following the day on which the Required Annual Filings are filed on SEDAR and a corresponding news release is issued by the Company.
The Company currently intends to make the required interim filings by July 15, 2020.
Matica is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc. is a Dorval, Quebec based Health Canada Licence Holder. RoyalMax has been granted a standard cultivation licence, standard processing and medical sales licences by Health Canada.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
Boris Ziger, CEO & Chairman
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
This news release contains statements about the Company’s information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56423
Cannabis3 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PharmaCielo Ltd. of Class Action Lawsuit and Upcoming Deadline – PCLOF
Cannabis4 weeks ago
Hemp, Inc. Featured in Politico Pro’s Coverage of The Hemp Industry Amidst The COVID-19 Pandemic
Cannabis2 weeks ago
Cronos Group Reports 2020 First Quarter Results
Cannabis4 weeks ago
Sun Kissed Subsidiary Hakuna’s Rapid Production Growth Occasions CEO Ilan Freeman’s Invitation to Discuss M&A, Revenue Growth and Product Development by Stock Market Podcast
Cannabis3 weeks ago
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)
Cannabis3 weeks ago
Sun Kissed’s Hakuna CEO Ilan Freeman’s Podcast Interview Discusses Acquisitions, Increased Profit Margins, 2020 Growth and Future Outlook
Cannabis4 weeks ago
SLANG Worldwide Announces Preliminary 2019 Financial Results and Provides Corporate Update
Cannabis4 weeks ago
Nass Valley Gateway Ltd Announces It Will Rely on the CSA Extension to File Its Q1 2020 Quarterly and 2019 Annual Financials and MD&A Reports